Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

China Biologic Produ (CBPO)

China Biologic Produ (CBPO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

China Biologic Produ 18TH FL JIALONG INTERNATIONALBUILDING 19 CHAOYANG PARK ROAD CHAOYANG DISTRICT BEIJING F4 100125 CHN

www.chinabiologic.com P: 86-10-6598-3111 F: 106-598-3222

Description:

China Biologic Products, Inc., through its indirect majority-owned subsidiary, is principally engaged in the research, development, production, manufacturing and sale of plasma-based biopharmaceutical products to hospitals and other health care facilities in China. Its subsidiary, Shandong Taibang Biological Products Co. Ltd., operates from its manufacturing facility located in Taian City, Shandong Province. The Company's principal products include its approved human albumin and immunoglobulin products. These human albumin products are mainly used to increase blood volume and its immunoglobulin products are used for the treatment and prevention of diseases.

Key Statistics

Overview:

Market Capitalization, $K 4,722,806
Shares Outstanding, K 39,360
Annual Sales, $ 524,370 K
Annual Net Income, $ 152,290 K
Last Quarter Sales, $ 112,100 K
Last Quarter Net Income, $ 23,680 K
60-Month Beta 0.42
% of Insider Shareholders 2.73%
% of Institutional Shareholders 35.55%
Float, K 38,285
% Float 97.27%

Growth:

1-Year Return 10.59%
3-Year Return 36.12%
5-Year Return 2.56%
5-Year Revenue Growth 76.88%
5-Year Earnings Growth 22.02%
5-Year Dividend Growth 0.00%

Per-Share Information:

Latest Earnings Date 05/19/21
Earnings Per Share ttm 4.03
EPS Growth vs. Prev Qtr -38.46%
EPS Growth vs. Prev Year 20.75%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

CBPO Ratios

Ratio
Price/Earnings ttm 29.28
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 8.24%
Return-on-Assets % 7.57%
Profit Margin % 29.04%
Debt/Equity 0.00
Price/Sales 9.06
Price/Cash Flow 25.34
Price/Book 2.27
Book Value/Share 52.89
Interest Coverage 669.94
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar